The effects of Δ12-PGJ2 on malignant cells☆
- 1 June 2000
- journal article
- review article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 62 (1) , 75-90
- https://doi.org/10.1016/s0090-6980(00)00076-9
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Characterization of a human melanoma cell line with nonoestrogen receptor dependent tamoxifen resistanceMelanoma Research, 1999
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998
- Induction of p53 and apoptosis by δ12‐PGJ2 in human hepatocarcinoma SK‐HEP‐1 cellsFEBS Letters, 1995
- Prostaglandin J2 and Related CompoundsAnnals of the New York Academy of Sciences, 1994
- p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.Genes & Development, 1994
- Prostaglandin A2 and Δ12‐prostaglandin J2 induce apoptosis in L1210 cellsFEBS Letters, 1993
- Cell growth inhibition by prostaglandin A2 results in elevated expression of gadd153 mRNAExperimental Cell Research, 1992
- Adjuvant effects of prostaglandin D2 to cisplatin on human ovarian cancer cell growth in nude miceEuropean Journal of Cancer and Clinical Oncology, 1988
- 9-Deoxy-Δ9-prostaglandin D2, a prostaglandin D2 derivative with potent antineoplastic and weak smooth muscle-contracting activitiesBiochemical and Biophysical Research Communications, 1982
- Prostaglandin D2 controls pulmonary metastasis of malignant melanoma cellsNature, 1979